NCT02899832

Brief Summary

This study will included 20 children presenting with epilepsy with spasms. It aims to offer these children, non invasively and without supplementary examinations, a recording of local and cerebral hemodynamic changes concomitant with an electroencephalographic recording during epileptic episodes. This will be carried out by combining optical imaging using near infra-red spectroscopy (NIRS) with electroencephalography (EEG), in a simultaneous high-resolution (HR) recording. This study is among those based on multimodal analyses of epilepsy, combining methods of analysis of electrical activity (electrical imaging) and hemodynamics (optical imaging). Surface electroencephalography (EEG) is a precious tool enabling the study of neuronal dysfunction from a functional point view. It is used in the routine follow-up of children with epilepsy. Optical imaging is a promising medical imaging technique. It uses light in the spectral regions of near infra-red as a source of radiation. It is quantitative, rapid, non invasive, and inoffensive which could easily be used at the child's bedside or in a clinical setting and can provide metabolic information about cerebral function. This study is multidisciplinary, which calls upon the skills of neurophysiologists, biophysicists, and clinicians

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2013

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2013

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 14, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

August 10, 2018

Status Verified

August 1, 2018

Enrollment Period

6.9 years

First QC Date

September 5, 2016

Last Update Submit

August 9, 2018

Conditions

Keywords

childrenspasms

Outcome Measures

Primary Outcomes (2)

  • changes in HbO

    hemodynamic changes in \[HbO\] before spasms, during spasms, and after spasms

    Day 0

  • changes in Hbr

    hemodynamic changes in \[Hbr\] before spasms, during spasms, and after spasms

    Day 0

Study Arms (1)

NIRS

Near Infra Red Spectroscopy.

Device: NIRS

Interventions

NIRSDEVICE

Near Infra Red Spectroscopy

NIRS

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children between 3 and 6 years old presenting infantile spasms

You may qualify if:

  • Children between 3 and 6 years old presenting infantile spasms according to the Classification of the International League Against Epilepsy

You may not qualify if:

  • Children younger than 3 months and older than 6 years of age, refusal of one of the parents, and dermatosis of the scalp

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU Amiens

Amiens, 80054, France

RECRUITING

Fondation Ophtalmologique Rothshild

Paris, 75019, France

RECRUITING

MeSH Terms

Conditions

EpilepsySpasm

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Fabrice WALLOIS, MD, PhD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fabrice WALLOIS, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2016

First Posted

September 14, 2016

Study Start

February 21, 2013

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

August 10, 2018

Record last verified: 2018-08

Locations